Dilantin and Nasonex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilantin (phenytoin sodium) and Nasonex (mometasone furoate monohydrate). Common drug interactions include sinusitis among females and convulsion among males.

The phase IV clinical study analyzes what interactions people have when they take Dilantin and Nasonex. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Dilantin?

Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.



On Jul, 25, 2026

64 people who take Dilantin and Nasonex together, and have interactions are studied.

Dilantin and Nasonex drug interactions.

What are the common drug interactions of Dilantin and Nasonex, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Cellulitis (infection under the skin)
  3. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  4. Gastritis (inflammation of stomach)
  5. Migraine (headache)
  6. Oropharyngeal pain
  7. Pain
  8. Productive cough
  9. Weight increased
  10. Abdominal pain

male:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Catatonia (unresponsive to external stimuli)
  3. Bruxism (habitual grinding of the teeth, typically during sleep)
  4. Drug toxicity
  5. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  6. Muscle twitching
  7. Muscular weakness (muscle weakness)
  8. Sudden death
  9. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  10. Balance disorder

What are the common drug interactions of Dilantin and Nasonex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Mental retardation (problems with learning and developing)
  3. Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
  4. Respiratory distress (difficulty in breathing)

20-29:

  1. Abdominal pain upper
  2. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  3. Anaemia (lack of blood)
  4. Arthralgia (joint pain)
  5. Ataxia (loss of full control of bodily movements)
  6. Atelectasis (partial or complete collapse of the lung)
  7. Back pain
  8. Bronchial hyperreactivity
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Cellulitis (infection under the skin)

30-39:

  1. Catatonia (unresponsive to external stimuli)
  2. Bruxism (habitual grinding of the teeth, typically during sleep)
  3. Sudden death
  4. Cardiac hypertrophy (thickening of the heart muscle)
  5. Confusional state
  6. Drug screen positive
  7. Insomnia (sleeplessness)
  8. Pain
  9. Post-traumatic epilepsy
  10. Anxiety

40-49:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Pancreatitis (inflammation of pancreas)
  3. Transaminases increased
  4. Urinary tract infection
  5. Anaemia (lack of blood)
  6. Pneumonia
  7. Hepatic enzyme increased
  8. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  9. Angioedema (rapid swelling of the dermis)
  10. Arteriosclerosis (thickening and hardening of arteries)

50-59:

  1. Acute sinusitis
  2. Alopecia (absence of hair from areas of the body)
  3. Anaemia (lack of blood)
  4. Arthropathy
  5. Asthma
  6. Back pain
  7. Blood alkaline phosphatase increased
  8. Breast mass
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)

60+:

  1. Headache (pain in head)
  2. Constipation
  3. Corneal oedema (corneal swelling)
  4. Diabetes mellitus inadequate control
  5. Diarrhoea
  6. Diastolic dysfunction
  7. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  8. Dizziness
  9. Drug diversion
  10. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

What are the existing conditions these people have? *

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 17 people, 26.56%
  2. Migraine (headache): 15 people, 23.44%
  3. High Blood Pressure: 14 people, 21.88%
  4. Pain: 13 people, 20.31%
  5. Hereditary Angioedema (recurrent episodes of severe swelling): 13 people, 20.31%
  6. Asthma: 12 people, 18.75%
  7. Hypersensitivity: 11 people, 17.19%
  8. Constipation: 10 people, 15.62%
  9. High Blood Cholesterol: 10 people, 15.62%
  10. Nausea (feeling of having an urge to vomit): 10 people, 15.62%

* Approximation only. Some reports may have incomplete information.

Do you take Dilantin and Nasonex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dilantin and Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dilantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phenytoin sodium and mometasone furoate monohydrate (the active ingredients of Dilantin and Nasonex, respectively), and Dilantin and Nasonex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: